Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason R Smith

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Neurology|June 10, 2026
Frailty as a Modifier of the Associations Between Vascular Risk Factors and Incident DementiaJason R Smith, A Richey Sharrett, James Russell Pike, et al.
Journal of Chemical Information and Modeling|March 17, 2023
Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent InhibitorsOlivia Garland, Anh-Tien Ton, Shoeib Moradi, et al.
Journal of Alzheimer'S Disease : JAD|October 17, 2025
Summary population attributable fraction of dementia prevalence associated with sensory risk factorsJason R Smith, Xi Wang, Wuyang Zhang, et al.
JAMA Neurology|June 2, 2025
Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident DementiaJason R Smith, James Russell Pike, Rebecca F Gottesman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 17, 2025
Population Attributable Fraction of Incident Dementia Associated With Hearing LossEmily Ishak, Emily A Burg, James Russell Pike, et al.
The Journal of Infectious Diseases|June 3, 2025
Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain ResistanceNatalie M Deschenes, Jimena Pérez-Vargas, Zoe Zhong, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Neurology|June 10, 2026
Frailty as a Modifier of the Associations Between Vascular Risk Factors and Incident DementiaJason R Smith, A Richey Sharrett, James Russell Pike, et al.
Journal of Chemical Information and Modeling|March 17, 2023
Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent InhibitorsOlivia Garland, Anh-Tien Ton, Shoeib Moradi, et al.
Journal of Alzheimer'S Disease : JAD|October 17, 2025
Summary population attributable fraction of dementia prevalence associated with sensory risk factorsJason R Smith, Xi Wang, Wuyang Zhang, et al.
JAMA Neurology|June 2, 2025
Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident DementiaJason R Smith, James Russell Pike, Rebecca F Gottesman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 17, 2025
Population Attributable Fraction of Incident Dementia Associated With Hearing LossEmily Ishak, Emily A Burg, James Russell Pike, et al.
The Journal of Infectious Diseases|June 3, 2025
Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain ResistanceNatalie M Deschenes, Jimena Pérez-Vargas, Zoe Zhong, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 5